• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER Back to Search Results
Model Number 10445
Device Problems Difficult to Insert (1316); Difficult to Remove (1528); Failure to Advance (2524); Material Deformation (2976)
Patient Problems Hemorrhage/Bleeding (1888); Perforation of Vessels (2135)
Event Date 10/28/2020
Event Type  Injury  
Manufacturer Narrative
Device eval by manufacturer: the reported sheath kink was confirmed.The reported insertion difficulty, difficulty advancing/removing ancillary device, vessel perforation and hemorrhage could not be confirmed via lab analysis as clinical circumstances could not be replicated.The returned product consisted of a 14f isleeve sheath.The tip of the device and 7.5cm of the sheath were pulled backwards into the proximal area of the sheath.The tip of the device and sheath were microscopically and visually inspected.Inspection revealed damage to the sheath which included numerous kinks, abrasions and crazing.The tip of the device had abrasions and was misshapen.Two of the three sheath seams were partially opened.The tip damage on the distal most end of the device is consistent with an ancillary device catching on the tip, thus being withdrawn backwards into the sheath.Procedural imaging and still images were provided to assist in the investigation.The procedural media was reviewed by a boston scientific medical safety director.In conclusion the media is consistent with allegation of damage to abdominal aorta (likely due to guide catheter) and damage to the distal part of the isleeve.There is also a mild residual pvl leak.There is no evidence of coronary obstruction by the valve, since the flow did not decrease after full valve deployment based on the recorded loops.It is more likely that the mi occurred in the context of severe existing cad aggravated by the procedural complications and likely hemodynamic instability.Two still images of the isleeve, once removed from patient and on table showed the tip is split and distal end is bunched up.
 
Event Description
It was reported that vessel perforation of the right femoral artery and retroperitoneal bleeding occurred.Procedure summary: the patient has a medical history of first-degree atrioventricular (av) block and coronary artery disease with previous unspecified stents implanted in the right coronary artery (rca).Vascular access was gained through the extremely small right femoral artery.The patients vasculature was severely stenotic with mild calcification and tortuosity.Resistance was felt during insertion of the 14f isleeve introducer sheath into the femoral artery.Once inserted, difficulty inserting an acurate neo2 valve loaded onto an acurate neo2 transfemoral delivery system (tf ds) was encountered, however the acurate neo2 valve system was able to be advanced and deployed in the native aortic annulus without issue.Resistance was encountered again when removing the acurate neo2 tf ds through the isleeve 14f introducer sheath however the acurate neo2 tf ds was able to be removed without issue.Angiograms were performed at the completion of the procedure and then the isleeve introducer sheath was removed from the patient.Upon removal of the isleeve introduce sheath two visible folds were noted on the sheath.There were no patient complications immediately following the procedure.Post procedure event summary: twenty four hours after the procedure, the patient suffered peritoneal bleeding.Computerized tomography (ct) revealed a small perforation in right femoral artery.No intervention was required as the bleeding spontaneously stopped on its own.The ct scan did not show any active bleeding.Additionally, the patient suffered complications of pericardial effusion and cardiac tamponade following a permanent pacemaker implant not related to the acurate neo2 valve implant.The acurate neo2 valve implant did not cause or worsen any conduction disturbances necessitating the pacemaker implant.Myocardial infarction occurred due to restenosis of the stents in the rca.An attempt at percutaneous coronary intervention of the rca was made, however the patient died.The cause of death was myocardial infarction.Per the physician the patient death was due to restenosis of the stented rca and not due to the transcatheter aortic valve implantation (tavi) procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISLEEVE 14F
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10906387
MDR Text Key218743139
Report Number2134265-2020-15832
Device Sequence Number1
Product Code DYB
UDI-Device Identifier08714729950660
UDI-Public08714729950660
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/23/2022
Device Model Number10445
Device Catalogue Number10445
Device Lot Number0025252118
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/11/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/29/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/24/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-